| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |